MeSH D006356 - heartburn
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| AbbVie | Famotidine | Famotidine |  | 2001-12-17 |  |  |
| Accord Healthcare | Esomeprazole | Esomeprazole |  | 2015-09-25 |  |  |
| Ajanta Pharma | Naproxen, Esomeprazole strontium | Naproxen Esomeprazole Magnesium |  | 2022-10-06 |  |  |
| Omeprazole | Omeprazole Bicarbonate |  | 2016-07-15 |  |  | |
| Pantoprazole | Pantoprazole |  | 2023-02-09 |  |  | |
| Famotidine | Famotidine |  | 2023-09-18 |  |  | |
| Akorn | Famotidine | Famotidine |  | 2014-05-30 |  |  |
| Alembic Pharmaceuticals | Famotidine | Famotidine |  | 2009-05-22 |  |  |
| Alkem Laboratories | Esomeprazole strontium | Esomeprazole Magnesium |  | 2017-10-20 |  |  |
| Famotidine, Ibuprofen | Ibuprofen Famotidine |  | 2021-08-03 |  |  | |
| Rabeprazole | Rabeprazole |  | 2018-04-24 |  |  | |
| Famotidine | Famotidine |  | 2022-01-07 |  |  | |
| Allergan | Famotidine | Famotidine |  | 2001-04-16 |  |  |
| Naproxen, Esomeprazole strontium | Naproxen Esomeprazole Magnesium |  | 2022-08-24 |  |  | |
| Nizatidine | Nizatidine |  | 2002-07-09 |  |  | |
| Omeprazole | Omeprazole |  | 2008-05-30 |  |  | |
| Pantoprazole | Pantoprazole |  | 2011-02-07 |  |  | |
| Amneal Pharmaceuticals | Esomeprazole strontium | Esomeprazole Magnesium |  | 2019-04-10 |  |  |
| Famotidine | Famotidine |  | 2022-08-04 |  |  | |
| Nizatidine | Nizatidine |  | 2009-11-18 |  |  | |
| Pantoprazole | Pantoprazole |  | 2016-01-26 |  |  | |
| Rabeprazole | Rabeprazole |  | 2015-07-31 |  |  | |
| ANDA Repository | Esomeprazole strontium | Esomeprazole Magnesium |  | 2023-03-15 |  |  |
| Omeprazole | Omeprazole Bicarbonate |  | 2020-04-30 |  |  | |
| ANI Pharmaceuticals | Nizatidine | Nizatidine |  | 2002-07-08 |  |  |
1
2
3
4
5
6
...
12
>
Clinical Trials
Historical Success Rate
Phase 1
88%7/8
Phase 2
71%5/7
Phase 3
81%17/21
Approved: 10Overall Success rate: 51%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
8
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use